13-101579297-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004791.3(ITGBL1):c.597G>T(p.Lys199Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,613,646 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
ITGBL1
NM_004791.3 missense
NM_004791.3 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 6.83
Genes affected
ITGBL1 (HGNC:6164): (integrin subunit beta like 1) This gene encodes a beta integrin-related protein that is a member of the EGF-like protein family. The encoded protein contains integrin-like cysteine-rich repeats. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGBL1 | NM_004791.3 | c.597G>T | p.Lys199Asn | missense_variant | 5/11 | ENST00000376180.8 | NP_004782.1 | |
ITGBL1 | NM_001271755.2 | c.450G>T | p.Lys150Asn | missense_variant | 4/10 | NP_001258684.1 | ||
ITGBL1 | NM_001271756.2 | c.318G>T | p.Lys106Asn | missense_variant | 4/10 | NP_001258685.1 | ||
ITGBL1 | NM_001271754.2 | c.174G>T | p.Lys58Asn | missense_variant | 4/11 | NP_001258683.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGBL1 | ENST00000376180.8 | c.597G>T | p.Lys199Asn | missense_variant | 5/11 | 1 | NM_004791.3 | ENSP00000365351 | P1 | |
ITGBL1 | ENST00000618057.4 | c.450G>T | p.Lys150Asn | missense_variant | 4/10 | 1 | ENSP00000481484 | |||
ITGBL1 | ENST00000376162.7 | c.318G>T | p.Lys106Asn | missense_variant | 4/10 | 2 | ENSP00000365332 | |||
ITGBL1 | ENST00000545560.6 | c.174G>T | p.Lys58Asn | missense_variant | 4/11 | 2 | ENSP00000439903 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251184Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135772
GnomAD3 exomes
AF:
AC:
6
AN:
251184
Hom.:
AF XY:
AC XY:
3
AN XY:
135772
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461446Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 727022
GnomAD4 exome
AF:
AC:
31
AN:
1461446
Hom.:
Cov.:
30
AF XY:
AC XY:
12
AN XY:
727022
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74344
GnomAD4 genome
AF:
AC:
1
AN:
152200
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74344
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.597G>T (p.K199N) alteration is located in exon 5 (coding exon 5) of the ITGBL1 gene. This alteration results from a G to T substitution at nucleotide position 597, causing the lysine (K) at amino acid position 199 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;.
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;D;T;D;T
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;L;.;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;.;N;N
REVEL
Uncertain
Sift
Benign
.;T;.;T;T
Sift4G
Benign
T;T;T;T;T
Polyphen
0.78
.;P;.;.;.
Vest4
MutPred
0.48
.;Gain of catalytic residue at H197 (P = 2e-04);.;.;.;
MVP
MPC
0.79
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at